KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insulet (PODD) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Insulet (PODD) over the last 16 years, with Q3 2025 value amounting to $2.2 million.

  • Insulet's Gains from Investment Securities rose 14444.44% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.8 million, marking a year-over-year increase of 47464.79%. This contributed to the annual value of $22.7 million for FY2024, which is 7196.97% up from last year.
  • Insulet's Gains from Investment Securities amounted to $2.2 million in Q3 2025, which was up 14444.44% from $1.7 million recorded in Q2 2025.
  • In the past 5 years, Insulet's Gains from Investment Securities ranged from a high of $26.1 million in Q1 2021 and a low of $100000.0 during Q4 2022
  • In the last 5 years, Insulet's Gains from Investment Securities had a median value of $1.2 million in 2021 and averaged $5.6 million.
  • As far as peak fluctuations go, Insulet's Gains from Investment Securities plummeted by 8333.33% in 2022, and later soared by 1560000.0% in 2024.
  • Insulet's Gains from Investment Securities (Quarter) stood at $600000.0 in 2021, then plummeted by 83.33% to $100000.0 in 2022, then changed by 0.0% to $100000.0 in 2023, then surged by 15600.0% to $15.7 million in 2024, then crashed by 85.99% to $2.2 million in 2025.
  • Its Gains from Investment Securities was $2.2 million in Q3 2025, compared to $1.7 million in Q2 2025 and $21.2 million in Q1 2025.